Atria Oyj financials
Atria Oyj
Country: FI Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
743700XLYONPSKO15Z91 Financial statements
(EUR, as reported — unscaled; 101 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €1.81B | €1.76B |
| Cost of sales | €1.62B | €1.56B |
| Gross profit | €198.0M | €191.3M |
| Other income | €4.5M | €4.6M |
| Administrative expenses | €58.4M | €52.5M |
| Operating profit (EBIT) | €64.0M | €66.4M |
| Net finance income / (cost) | -€10.7M | -€15.4M |
| Finance costs | €18.1M | €25.0M |
| Profit before tax | €53.6M | €52.1M |
| Income tax expense | €10.0M | €9.1M |
| Profit for the year | €43.6M | €43.0M |
| — attributable to owners | €40.7M | €39.7M |
| — attributable to NCI | €2.9M | €3.3M |
| Total comprehensive income | €51.3M | €34.2M |
| Per share | ||
| Basic EPS | €1.44 | €1.41 |
| Diluted EPS | €1.44 | €1.41 |
| Free cash flow / share | €2.18 | €1.76 |
| Cash flow statement | ||
| Net cash from operating activities | €120.0M | €92.4M |
| Net cash from investing activities | -€50.2M | -€50.8M |
| Purchase of PP&E (capex) | €54.1M | €38.7M |
| Net cash from financing activities | -€58.7M | -€32.3M |
| Dividends paid | €20.8M | €19.0M |
| Lease liability payments | €10.6M | €9.5M |
| Net change in cash | €11.1M | €9.3M |
| Balance sheet | ||
| Total assets | €999.4M | €984.8M |
| Non-current assets | €729.5M | €725.2M |
| Property, plant & equipment | €530.1M | €524.0M |
| Right-of-use assets | €17.9M | €22.8M |
| Intangible assets & goodwill | €84.5M | €82.3M |
| Current assets | €269.9M | €259.6M |
| Inventories | €128.3M | €125.9M |
| Trade & other receivables | €105.9M | €105.0M |
| Cash & equivalents | €30.9M | €19.9M |
| Total equity | €454.8M | €423.7M |
| — attributable to owners | €432.0M | €402.4M |
| Non-controlling interests | €22.8M | €21.3M |
| Non-current liabilities | €285.3M | €315.6M |
| Long-term borrowings | €226.0M | €253.6M |
| Lease liabilities (non-current) | €9.6M | €14.2M |
| Current liabilities | €259.3M | €245.5M |
| Lease liabilities (current) | €9.0M | €9.1M |
| Trade & other payables | €241.8M | €230.2M |
| Deferred tax liabilities | €33.1M | €34.0M |
| Derived metrics | ||
| Free cash flow | €65.9M | €53.7M |
| Operating margin | 3.5% | 3.8% |
| Net margin | 2.4% | 2.4% |
| Return on equity | 9.6% | 10.1% |
| Cash conversion ratio | 2.75× | 2.15× |
| Capex coverage | 2.22× | 2.39× |
| Other reported items | ||
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | -€3.2M | €2.6M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €694.0K |
| Cash Flows From Used In Decrease Increase In Shortterm Deposits and Investments | -€797.0K | -€1.2M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €11.4M |
| Comprehensive Income Attributable To Noncontrolling Interests | €2.9M | €3.3M |
| Comprehensive Income Attributable To Owners of Parent | €48.5M | €30.9M |
| Current Biological Assets | €4.5M | €5.3M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €5.0M | €4.8M |
| Current Tax Assets Current | €256.0K | €3.4M |
| Current Tax Liabilities Current | €3.5M | €1.4M |
| Deferred Tax Assets | €3.5M | €2.5M |
| Dividends Received Classified As Investing Activities | €435.0K | €555.0K |
| Dividends Recognised As Distributions To Owners Per Share | €0.69 | €0.30 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€138.0K | €573.0K |
| Equity and Liabilities | €999.4M | €984.8M |
| Finance Income | €7.4M | €9.5M |
| Gains Losses On Cash Flow Hedges Net of Tax | €1.1M | -€4.9M |
| Gains Losses On Exchange Differences On Translation Net of Tax | €6.1M | -€3.4M |
| Income Taxes Paid Refund Classified As Operating Activities | €6.0M | €6.9M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €100.0K | -€2.9M |
| Increase Decrease Through Sharebased Payment Transactions | €469.0K | — |
| Intangible Assets Other Than Goodwill | €59.7M | €59.7M |
| Interest Paid Classified As Operating Activities | €19.3M | €25.4M |
| Interest Received Classified As Operating Activities | €7.2M | €9.7M |
| Investment Accounted For Using Equity Method | €21.1M | €21.3M |
| Issued Capital | €48.1M | €48.1M |
| Liabilities | €544.6M | €561.1M |
| Noncurrent Biological Assets | €498.0K | €597.0K |
| Noncurrent Provisions | €3.1M | €58.0K |
| Noncurrent Receivables | €8.6M | €9.3M |
| Other Cash Payments From Operating Activities | €1.67B | €1.65B |
| Other Cash Receipts From Operating Activities | €4.5M | €2.8M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €1.1M | -€4.9M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €6.1M | -€3.4M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €598.0K | -€551.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Revaluation | €0 | €0 |
| Other Expense By Function | €7.8M | €3.0M |
| Other Noncurrent Financial Assets | €3.7M | €2.8M |
| Other Noncurrent Financial Liabilities | €8.6M | €8.5M |
| Other Reserves | €116.0K | -€1.4M |
| Payments From Changes In Ownership Interests In Subsidiaries | €0 | €2.9M |
| Proceeds From Current Borrowings | €239.0K | €21.0M |
| Proceeds From Noncurrent Borrowings | €6.0M | €800.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €1.0M | €1.9M |
| Receipts From Sales of Goods and Rendering of Services | €1.81B | €1.77B |
| Recognised Liabilities Defined Benefit Plan | €4.8M | €5.3M |
| Repayments of Current Borrowings | €0 | €20.0M |
| Repayments of Noncurrent Borrowings | €33.5M | €2.6M |
| Reserve of Exchange Differences On Translation | -€15.0M | -€21.1M |
| Retained Earnings | €160.0M | €138.1M |
| Sales and Marketing Expense | €72.2M | €74.0M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €246.0K | €1.1M |
Methodology
Every line item above is a fact tagged in Atria Oyj's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.